Product Images Levetiracetam In Sodium Chloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 12 images provide visual information about the product associated with Levetiracetam In Sodium Chloride NDC 14789-220 by Nexus Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

lev1g 0007 01

lev1g 0007 01

lev1g 0007 02

lev1g 0007 02

lev1g 0007 03

lev1g 0007 03

lev1g 0007 04

lev1g 0007 04

lev1g 0007 05

lev1g 0007 05

lev1g 0007 06

lev1g 0007 06

lev1g 0007 07

lev1g 0007 07

Levetiracetam in 0.82% Sodium Chloride Injection is a medication that is intended for intravenous use only. It is recommended to infuse it over a period of 15 minutes. Each 100 mL contains 500 mg levetiracetam, 820 mg sodium chloride, 5.5 mg of glacial acetic acid and buffered at around pH 5.5 with glacial acetic acid and 164 mg sodium acetate trihydrate. The medication is stored at 20°C to 25°C (68°F to 77°F) and should not be further diluted prior to use. The package insert should be consulted for the usual dosage. Levetiracetam in 0.82% Sodium Chloride Injection comes in single-use bags packaged in an aluminum overwrap and inner polypropylene overwrap.*

lev1g 0007 08

lev1g 0007 08

NDC 14789-110-08 is a prescription-only medication containing Levetiracetam in Sodium Chloride Injection. It is available in a 100 mL single-dose container to be used for intravenous infusion only. The container should not be diluted before use, and the medication should be infused over a period of 15 minutes. The medication should be used promptly after opening the overwrap. The usual dosage should be determined based on the package insert. The medication should be stored at 20 to 25°C (68 to 77°F) and should not be stored in plastic containers in series. The medication is manufactured in the UK for Nexus Pharmaceuticals, Inc. and is a single-use dual port bag. Specific lot and expiration information is not available.*

lev1g 0007 09

lev1g 0007 09

Levetiracetam is a medication that is intended for intravenous infusion only for use as per the package insert. Each 100L of the medication includes 1000mg of levetiracetam and is infused over a period of 15 minutes. The medication is packaged in plastic overwrap and is not recommended for use if the overwrap has already been opened or damaged before use. The solution of the medication includes 750g of sodium chloride, 6.5m of glacial acetic acid, and is buffered to pH 5.5. The recommended storage temperature for the medication is between 20°C to 25°C. The container closure does not contain natural rubber latex.*

lev1g 0007 10

lev1g 0007 10

This is a prescription medicine with the NDC code 14789-220-08. It is a single-dose container containing 100 mL of Levetiracetam in 0.75% Sodium Chloride Injection with a concentration of 1000 mg/100 mL (10 mg/mL). It should be infused over a period of 15 minutes and should not be further diluted prior to use. The usual dosage should be referred to in the package insert. The medication should not be used with plastic containers in series connections. The recommended storage is at 20 to 25°C (68 to 77°F). It is a single-use dual port bag manufactured in the UK for Nexus Pharmaceuticals, Inc. in Lincolnshire, IL.*

lev1g 0007 11

lev1g 0007 11

This is a medication called Levetiracetam that is infused intravenously over a 15-minute period. The usual dosage is specified in the package insert. Each 100ml of Levetiracetam injection contains 1500mg of levetiracetam, water for injection, 540 mg of sodium chloride, and 7.5 mg of glacial acetic acid. The solution is buffered at about pH 5.5 by glacial acetic acid and 164 g of sodium acetate trihydrate. The medication is stored in single-use bags that are wrapped in plastic overwrap. The wrap should be removed and checked for leaks before use. The medication should be used promptly once the plastic overwrap is removed. The instruction specifies that plastic containers should not be used in series connections. Lastly, the container closure is not made of natural rubber latex, and the medication is only for intravenous infusion.*

lev1g 0007 12

lev1g 0007 12

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.